

Dev Kantesaria: Great Compounding Machines That Crush The Market (Plus, New Stocks He Has Bought) $FICO $V $MA $SPGI + More
Aug 27, 2025
Discover the unique journey of Dev Kantesaria from medicine to finance and his application of Buffett's principles in investing. Explore the allure of capital-light businesses with strong margins like FICO, Visa, and Mastercard. Learn about S&P Global's resilience and pricing power since the 2008 crisis, showcasing its impressive growth. Dive into Kantesaria's portfolio strategy, emphasizing misunderstood profitability and steady returns, while contemplating the future of investment in the era of AI advancements.
AI Snips
Chapters
Transcript
Episode notes
Operating Experience Shapes Investment Edge
- Dev Kantesaria transitioned from medicine and VC to public investing, using operational experience to assess companies.
- He leverages director and CEO experience to evaluate public businesses beyond financial metrics.
Quality, Predictability, And Compounding Focus
- Valley Forge targets industry leaders with strong organic growth, predictable earnings, and capital efficiency.
- The fund focuses on compounding machines and avoids short-term trading or 'cigar butt' picks.
A Portfolio Of Elite, High-Margin Businesses
- His portfolio skews extremely large-cap with a $237B weighted average market cap and 47% operating margins.
- These metrics reveal concentrated ownership of high-margin, durable-moat businesses.